| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.089 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |